Cargando…

Semi-supervised vision transformer with adaptive token sampling for breast cancer classification

Various imaging techniques combined with machine learning (ML) models have been used to build computer-aided diagnosis (CAD) systems for breast cancer (BC) detection and classification. The rise of deep learning models in recent years, represented by convolutional neural network (CNN) models, has pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Jiang, Ran, Cui, Ning, Li, Qian, Yuan, Feng, Xiao, Zhifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353650/
https://www.ncbi.nlm.nih.gov/pubmed/35935827
http://dx.doi.org/10.3389/fphar.2022.929755
_version_ 1784762906841186304
author Wang, Wei
Jiang, Ran
Cui, Ning
Li, Qian
Yuan, Feng
Xiao, Zhifeng
author_facet Wang, Wei
Jiang, Ran
Cui, Ning
Li, Qian
Yuan, Feng
Xiao, Zhifeng
author_sort Wang, Wei
collection PubMed
description Various imaging techniques combined with machine learning (ML) models have been used to build computer-aided diagnosis (CAD) systems for breast cancer (BC) detection and classification. The rise of deep learning models in recent years, represented by convolutional neural network (CNN) models, has pushed the accuracy of ML-based CAD systems to a new level that is comparable to human experts. Existing studies have explored the usage of a wide spectrum of CNN models for BC detection, and supervised learning has been the mainstream. In this study, we propose a semi-supervised learning framework based on the Vision Transformer (ViT). The ViT is a model that has been validated to outperform CNN models on numerous classification benchmarks but its application in BC detection has been rare. The proposed method offers a custom semi-supervised learning procedure that unifies both supervised and consistency training to enhance the robustness of the model. In addition, the method uses an adaptive token sampling technique that can strategically sample the most significant tokens from the input image, leading to an effective performance gain. We validate our method on two datasets with ultrasound and histopathology images. Results demonstrate that our method can consistently outperform the CNN baselines for both learning tasks. The code repository of the project is available at https://github.com/FeiYee/Breast-area-TWO.
format Online
Article
Text
id pubmed-9353650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93536502022-08-06 Semi-supervised vision transformer with adaptive token sampling for breast cancer classification Wang, Wei Jiang, Ran Cui, Ning Li, Qian Yuan, Feng Xiao, Zhifeng Front Pharmacol Pharmacology Various imaging techniques combined with machine learning (ML) models have been used to build computer-aided diagnosis (CAD) systems for breast cancer (BC) detection and classification. The rise of deep learning models in recent years, represented by convolutional neural network (CNN) models, has pushed the accuracy of ML-based CAD systems to a new level that is comparable to human experts. Existing studies have explored the usage of a wide spectrum of CNN models for BC detection, and supervised learning has been the mainstream. In this study, we propose a semi-supervised learning framework based on the Vision Transformer (ViT). The ViT is a model that has been validated to outperform CNN models on numerous classification benchmarks but its application in BC detection has been rare. The proposed method offers a custom semi-supervised learning procedure that unifies both supervised and consistency training to enhance the robustness of the model. In addition, the method uses an adaptive token sampling technique that can strategically sample the most significant tokens from the input image, leading to an effective performance gain. We validate our method on two datasets with ultrasound and histopathology images. Results demonstrate that our method can consistently outperform the CNN baselines for both learning tasks. The code repository of the project is available at https://github.com/FeiYee/Breast-area-TWO. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9353650/ /pubmed/35935827 http://dx.doi.org/10.3389/fphar.2022.929755 Text en Copyright © 2022 Wang, Jiang, Cui, Li, Yuan and Xiao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Wei
Jiang, Ran
Cui, Ning
Li, Qian
Yuan, Feng
Xiao, Zhifeng
Semi-supervised vision transformer with adaptive token sampling for breast cancer classification
title Semi-supervised vision transformer with adaptive token sampling for breast cancer classification
title_full Semi-supervised vision transformer with adaptive token sampling for breast cancer classification
title_fullStr Semi-supervised vision transformer with adaptive token sampling for breast cancer classification
title_full_unstemmed Semi-supervised vision transformer with adaptive token sampling for breast cancer classification
title_short Semi-supervised vision transformer with adaptive token sampling for breast cancer classification
title_sort semi-supervised vision transformer with adaptive token sampling for breast cancer classification
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353650/
https://www.ncbi.nlm.nih.gov/pubmed/35935827
http://dx.doi.org/10.3389/fphar.2022.929755
work_keys_str_mv AT wangwei semisupervisedvisiontransformerwithadaptivetokensamplingforbreastcancerclassification
AT jiangran semisupervisedvisiontransformerwithadaptivetokensamplingforbreastcancerclassification
AT cuining semisupervisedvisiontransformerwithadaptivetokensamplingforbreastcancerclassification
AT liqian semisupervisedvisiontransformerwithadaptivetokensamplingforbreastcancerclassification
AT yuanfeng semisupervisedvisiontransformerwithadaptivetokensamplingforbreastcancerclassification
AT xiaozhifeng semisupervisedvisiontransformerwithadaptivetokensamplingforbreastcancerclassification